CS logo
small CS logo
Clinique Chenieux; Oncology

Limoges, France

About Clinique Chenieux; Oncology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Clinique Chenieux; Oncology


During the past decade, Clinique Chenieux; Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Chenieux; Oncology" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Clinique Chenieux; Oncology


According to Clinical.Site data, the most researched conditions in "Clinique Chenieux; Oncology" are "Breast Cancer" (2 trials), "Bladder Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Colorectal Cancer" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Clinique Chenieux; Oncology" in a lesser frequency.

Clinical Trials Intervention Types at Clinique Chenieux; Oncology


Most popular intervention types in "Clinique Chenieux; Oncology" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (3 trials), "Atezolizumab" (2 trials), "Docetaxel" (2 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Clinique Chenieux; Oncology


The vast majority of trials in "Clinique Chenieux; Oncology" are 6 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Clinique Chenieux; Oncology


Currently, there are NaN active trials in "Clinique Chenieux; Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Clinique Chenieux; Oncology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Clinique Chenieux; Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".